Prevention and adherence in Rheumatic and Musculoskeletal disease

Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101525. doi: 10.1016/j.berh.2020.101525. Epub 2020 May 13.

Abstract

Rheumatic and Musculoskeletal Diseases (RMDs) are chronic conditions that affect a substantial number of people. RMDs are significantly related to co-morbidity. Therefore, focusing on prevention in RMDs is of importance to promote and maintain health. Prevention includes primary-, secondary-, tertiary-, and clinical prevention. Primary prevention aims to prevent the onset of disease before the disease process begins, secondary prevention includes detecting and reducing disease and risk factors at the earliest possible point, and tertiary prevention aims to limit the influence of a recognized or verified disease and to address or reduce further development or worsening of the disease, including physical and psychosocial disability. Clinical prevention attempts to integrate prevention into the disease management to limit disease progression and prevent complications and relapse. This chapter will focus on the evidence for prevention and highlight how innovations and trends can contribute by using digital technologies as an example.

Keywords: Adherence; Prevention; Self-management; Telehealth; eHealth.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chronic Disease
  • Comorbidity
  • Disease Management*
  • Humans
  • Musculoskeletal Diseases* / epidemiology
  • Musculoskeletal Diseases* / prevention & control
  • Rheumatic Diseases* / epidemiology
  • Rheumatic Diseases* / prevention & control